March 31, 2003

1 Min Read
Nutrition 21, Diabetex Form Alliance


Nutrition 21, Diabetex Form Alliance

PURCHASE, N.Y.--Nutrition 21 Inc. and DiabetexCorp. formed an alliance to conduct a clinical study on Diachrome, Nutrition21's patented combination of chromium picolinate and biotin. In the doubleblind, placebo-controlled study, researchers will investigate Diachrome's effecton glucose management and cholesterol levels in conjunction with prescriptionmedication in 600 patients with Type II diabetes.

"Nutrition 21's partnership with a well-respected,patient-focused disease management company like Diabetex represents asignificant milestone for our company as we move aggressively forward in thedevelopment and marketing of our chromium-based, patented portfolio of brandedproducts," said Gail Montgomery, president and chief executive officer ofNutrition 21 (www.nutrition21.com). Thecompany is also conducting a study in cooperation with Children's Hospital inOakland, Calif., to evaluate the efficacy of Diachrome in the juvenile Type IIdiabetes population.

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like